[Treatment of multiple sclerosis with levamisole and azathioprine. Comparison of the effectiveness, of an 'immunostimulative' and 'immunosuppressive' treatment (author's transl)].

Suppr

超能文献

作者信息

Patzold U, Haller P, Haas J, Pocklington P, Deicher H

出版信息

Nervenarzt. 1978 May;49(5):285-94.

PMID:673085

Abstract

摘要

相似文献

[Treatment of multiple sclerosis with levamisole and azathioprine. Comparison of the effectiveness, of an 'immunostimulative' and 'immunosuppressive' treatment (author's transl)].

Nervenarzt. 1978 May;49(5):285-94.

[Immunosuppressive treatment of multiple sclerosis. 3. Results of treatment with azathioprine and antilymphocytic globulin (author's transl)].

MMW Munch Med Wochenschr. 1974 Nov 29;116(48):2105-12.

[Immunosuppressive treatment of multiple sclerosis. 4. Results of treatment with azathioprine and antilymphocyte globulin (author's transl)].

MMW Munch Med Wochenschr. 1977 Sep 2;119(35):1111-4.

[Treatment of multiple sclerosis by Azathioprine. About 77 cases studied during 10 years (author's transl)].

Rev Neurol (Paris). 1978 Mar;134(3):215-22.

[Comparative analysis of the use of levamisole and pyrogenal in the treatment of multiple sclerosis].

Zh Nevropatol Psikhiatr Im S S Korsakova. 1985;85(3):366-7.

[Immunosuppressive therapy of multiple sclerosis using cyclophosphamide and imuran. Report on 57 cases].

Dtsch Gesundheitsw. 1972 Oct 12;27(41):1955-61.

[Prolonged treatment of multiple sclerosis with average doses of azathioprine. An evaluation of 15 years' experience].[硫唑嘌呤平均剂量对多发性硬化症的长期治疗。15年经验评估]

Rev Neurol (Paris). 1984;140(10):553-8.

Further observations on the effect of azathioprine on chronic nonremitting multiple sclerosis.

Trans Am Neurol Assoc. 1978;103:209-12.

[Levamisole treatment in multiple sclerosis and spastic pyramidal syndromes].

Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir. 1982 Apr-Jun;27(2):125-35.

Azathioprine in multiple sclerosis: the cons.硫唑嘌呤治疗多发性硬化症：反对观点

Neurology. 1988 Jul;38(7 Suppl 2):24-7.

引用本文的文献

Azathioprine for people with multiple sclerosis.硫唑嘌呤用于多发性硬化症患者。

Cochrane Database Syst Rev. 2024 Dec 9;12(12):CD015005. doi: 10.1002/14651858.CD015005.pub2.

Problems with rating scales for multiple sclerosis: a novel approach--the CAMBS score.多发性硬化症评定量表的问题：一种新方法——CAMBS评分

J Neurol. 1993;240(4):209-15. doi: 10.1007/BF00818706.

Modulation of immunity in multiple sclerosis: a double-blind levamisole-placebo controlled study in 85 patients.

J Neurol. 1982;228(1):65-72. doi: 10.1007/BF00313411.

Azathioprine in multiple sclerosis--a 3 year controlled study of its effectiveness.硫唑嘌呤治疗多发性硬化症——一项关于其疗效的3年对照研究

J Neurol. 1980;223(2):97-117. doi: 10.1007/BF00313173.

Immune complexes in multiple sclerosis: relation to clinical pattern.多发性硬化症中的免疫复合物：与临床模式的关系。

J Neurol. 1980;222(4):249-60. doi: 10.1007/BF00313154.

Four year double-blind controlled study of levamisole in multiple sclerosis.

Ital J Neurol Sci. 1990 Dec;11(6):595-9. doi: 10.1007/BF02337444.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验